We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
For the first time in the UK, obese patients and people who are overweight with weight-related health problems could now have access to Mounjaro, currently used for Type 2 diabetes, to help manage their weight and support weight loss.
More people living with obesity will have access to the newest and most effective obesity drugs to help cut NHS waiting lists, following the announcement of a £40 million two-year pilot today [Wednesday 7 June].
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
Fake, potentially harmful Ozempic and Saxenda pens have been found in the UK: you should only access these medicines via a medical prescription.
From brussels sprouts to dodgy diet products, these tips from the MHRA will help you stay safe during the festive season and beyond
Get help to classify herbal medicines, vitamins, food preparations, supplements and tonics for import and export.
Advice for medical professionals to follow when assessing drivers with diabetes mellitus.
The review of the safety of isotretinoin has concluded.
Torrent Pharma (UK) Limited is recalling certain batches of Ramipril 1.25mg tablets as a precautionary measure due to these batches having a low assay and high related substances test results after their release to the market.
Kieron Banks (34) was sentenced today at the Nightingale Court in Wolverhampton for the illegal possession and intent to supply prescription-only medication valued at over £2m following investigations by the Medicines and Healthcare products Regulatory Agency (MHRA).
You may need to tell DVLA if you have diabetes, depending on the treatment you're getting
Statistics on primary school children who are overweight, measured in reception and year 6 and presented for different ethnic groups.
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
Check the tariff classification for vitamin gummies.
Information to support your recovery after COVID-19.
Check the tariff classification for peptide nisin standardised with sodium chloride
These publications provide analyses and data that are not classified as research or official statistics.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.